Gene · 4090
Papers3,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor-infiltrating lymphocyte transfusion in a patient with treatment refractory triple negative breast cancer. | Cancer Rep (Hoboken) | 2023 | 37750497 | PubTator, text mining | PubMed |
| Response of cells and tissues to shear stress. | J Cell Sci | 2023 | 37747423 | PubTator, text mining | PubMed |
| Biological therapies for premature ovarian insufficiency: what is the evidence? | Front Reprod Health | 2023 | 37744287 | PubTator, text mining | PubMed |
| Elevated BMPR2 expression amplifies osteoblast differentiation in ankylosing spondylitis. | J Rheum Dis | 2023 | 37736586 | PubTator, text mining | PubMed |
| Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity. | Cell Rep Med | 2023 | 37734378 | PubTator, text mining | PubMed |
| Preclinical Evidence for the Use of Oral Mesenchymal Stem Cell-Derived Extracellular Vesicles in Bone Regenerative Therapy: A Systematic Review. | Stem Cells Transl Med | 2023 | 37715961 | PubTator, text mining | PubMed |
| Characterization of Fibrodysplasia Ossificans Progessiva relevant Acvr1/Acvr2 Activin receptors in medaka (Oryzias latipes). | PLoS One | 2023 | 37708126 | PubTator, text mining | PubMed |
| Multimodal roles of transient receptor potential channel activation in inducing pathological tissue scarification. | Front Immunol | 2023 | 37705977 | PubTator, text mining | PubMed |
| High BMP7 expression is associated with poor prognosis in ovarian cancer. | J Cell Mol Med | 2023 | 37688374 | PubTator, text mining | PubMed |
| SMAD Proteins in TGF-β Signalling Pathway in Cancer: Regulatory Mechanisms and Clinical Applications. | Diagnostics (Basel) | 2023 | 37685308 | PubTator, text mining | PubMed |
| Human iPSCs as Model Systems for BMP-Related Rare Diseases. | Cells | 2023 | 37681932 | PubTator, text mining | PubMed |
| Review on the protective activity of osthole against the pathogenesis of osteoporosis. | Front Pharmacol | 2023 | 37680712 | PubTator, text mining | PubMed |
| Fluid shear stress-modulated chromatin accessibility reveals the mechano-dependency of endothelial SMAD1/5-mediated gene transcription. | iScience | 2023 | 37680470 | PubTator, text mining | PubMed |
| Circ_0001825 promotes osteogenic differentiation in human-derived mesenchymal stem cells via miR-1270/SMAD5 axis. | J Orthop Surg Res | 2023 | 37674252 | PubTator, text mining | PubMed |
| Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson's disease. | Transl Neurodegener | 2023 | 37667404 | PubTator, text mining | PubMed |
| Kartogenin delivery systems for biomedical therapeutics and regenerative medicine. | Drug Deliv | 2023 | 37665332 | PubTator, text mining | PubMed |
| Mobilisation of jerboa kidney gene networks during dehydration and opportunistic rehydration. | iScience | 2023 | 37664605 | PubTator, text mining | PubMed |
| Separating friend from foe: Inhibition of TGF-β-induced detrimental SMAD1/5/9 phosphorylation while maintaining protective SMAD2/3 signaling in OA chondrocytes. | Osteoarthritis Cartilage | 2023 | 37652257 | PubTator, text mining | PubMed |
| GLIS3, a novel prognostic indicator of gastric adenocarcinoma, contributes to the malignant biological behaviors of tumor cells via modulating TGF-β1/TGFβR1/Smad1/5 signaling pathway. | Cytokine | 2023 | 37651918 | PubTator, text mining | PubMed |
| Widespread effects of DNA methylation and intra-motif dependencies revealed by novel transcription factor binding models. | Nucleic Acids Res | 2023 | 37650641 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4090/papers?page=8